• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Start-Up Stadium Wednesday Afternoon

Wednesday, June 05, 2024
5B
Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2024 BIO International Convention select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback. This year will also feature evaluation of the presentations from seed-stage company finalists (less than $1M raised) separate from emerging company finalists (more than $1M but less than $10M raised to date). with a winner identified for each category. Past prizes have included 'fast-track' admission review to incubator programs at the Illumina Accelerator and The Innovation Space, as well as complimentary, one-year memberships in the Biotechnology Innovation Organization with access to the cost-savings programs of BIO Business Solutions.
Loading
2:00 PM – 4:00 PM
(PST)
  1. AcroCyte Therapeutics is a cell-based precision medicine company. Our current focus lies in utilizing our core technology R3CE—rapid, reproducible, rare cell expansion— to assist clinical treatment and scientific research.
    SUS
    • Tools/Drug Development Support Tech
  2. AgenT is a French life sciences company on a mission to defeat Alzheimer's by targeting the silent phase.
    SUS
    • CNS/Neurological
  3. GelSana's novel polymers improve healing in impaired wounds, particularly in chronic wounds with high inflammation.
    SUS
    • Inflammation
  4. Incircular's mission is to advance Biotech and Pharma applications by effective stabilization of proteins using INCYPRO, a cutting-edge chemical protein engineering technology.
    SUS
    • Tools/Drug Development Support Tech
  5. Keliomics is an emerging biotechnology company whose breakthrough platform for organ-scale biology preserves the full composition, structure, and function of primary human tissues.
    SUS
    • Tools/Drug Development Support Tech
  6. Longieva has been developing novel therapeutics for validated targets for CNS disorders with utility in neurodegeneration (such as Alzheimer's and Parkinson's) and addictive disorders.
    SUS
    • CNS/Neurological
  7. Founded in 2018 and headquartered in Derio (Bizkaia), Mikrobiomik is a bio-pharmaceutical company created to conduct research, develop and manufacture of medicines based on the human microbiome.
    SUS
    • Platform for Therapeutics
  8. Neuroene is developing mitochondrial-protective small molecules for epilepsy, Parkinson's and mitochondrial diseases.
    SUS
    • CNS/Neurological
  9. Orlia provides optimization tools to maximize yield and improve cell health and viability in bioreactors and fermenters.
    SUS
    • Tools/Drug Development Support Tech
  10. SiNON has developed a patented tunable carbon nanoparticle that acts as a ‘Trojan horse' drug delivery platform that allows drugs to cross the blood brain barrier to treat many different neurological diseases.
    SUS
    • CNS/Neurological
  11. VoxCell is creating human-like vascularized tissue models as a screening platform in drug development; by combining Canada's first high-resolution 3D bioprinter, VoxCell's proprietary universal bioinks and VoxCell's vascularization software.
    SUS
    • Tools/Drug Development Support Tech

 
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS